The Relationship Between the Flow of Arteriovenous Fistula and Cardiac Function in Haemodialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-04-30

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective longitudinal surveillance for a period of 2 months. Sample - identify suitable Chronic Kidney Disease (CKD) patients who undergo HD with functioning AVF. Participants at various age range and both sexes are recruited to observe their access flow, access recirculation and cardiac function and assess their relationship.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Role of Regular Surveillance on Maintenance of Patency of an Arteriovenous Access

NCT04098159

Hemodialysis Access Failure

UNKNOWN NA

Clinical Values of Mature Fistulas in Hemodialysis

NCT04416971

Hemodialysis Access Failure Hemodialysis Complication

UNKNOWN

Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula

NCT06199609

End Stage Renal Disease Arteriovenous Fistula

COMPLETED

Vascular Access Choice and Outcomes in the Elderly and Very Elderly With End Stage Renal Disease in China

NCT02272374

End Stage Renal Disease

UNKNOWN NA

Access Flow Based Intervention for Management of Arteriovenous Hemodialysis Access Dysfunction.

NCT02628119

Hemodialysis Arteriovenous Fistula Maturation Failure

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients recruited who met the inclusion criteria were investigated access flow, access recirculation and cardiac function(including cardiac output,cardiac index,central blood volume,et al).Measurement time is the beginning of HD session (first 30min to 1 hr),Middle of HD session (optional),and the end of the HD session (1hr to 30 min prior to end of session). The follow-up duration is 6 months and 12 months.Repeat the assessment at the above time points.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complication of Hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergo HD with native AVF
* AF of AVF between 300ml/min and 1800ml/min

Exclusion Criteria

* Patients whose AVF developed Access Recirculation (AR) which cannot be resolved at the time of measurement
* Patients developed access or systemic infection during the study period

Minimum Eligible Age

16 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No